ArticleMediterranean journal of hematology and infectious diseases2022

The Venetoclax/Azacitidine Combination Targets the Disease Clone in Acute Myeloid Leukemia, Being Effective and Safe in a Patient with COVID-19.

Antonio Cristiano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.